Next Article in Journal
Apoptogenic Metabolites in Fractions of the Benthic Diatom Cocconeis scutellum parva
Previous Article in Journal
Analysis of the Toxicity and Histopathology Induced by the Oral Administration of Pseudanabaena galeata and Geitlerinema splendidum (Cyanobacteria) Extracts to Mice
Article Menu

Export Article

Open AccessReview
Mar. Drugs 2014, 12(1), 525-546;

Marine Natural Products with P-Glycoprotein Inhibitor Properties

Center for Drug Discovery and Biodiversity, Institute for Scientific Research and Technology Services (INDICASAT), Clayton, City of Knowledge, P.O. Box 0843-01103, Panama
Department of Biotechnology, Acharya Nagarjuna University, Nagarjuna Nagar, Guntur 522510, India
Author to whom correspondence should be addressed.
Received: 22 November 2013 / Revised: 6 January 2014 / Accepted: 7 January 2014 / Published: 22 January 2014
Full-Text   |   PDF [950 KB, uploaded 24 February 2015]   |  


P-glycoprotein (P-gp) is a protein belonging to the ATP-binding cassette (ABC) transporters superfamily that has clinical relevance due to its role in drug metabolism and multi-drug resistance (MDR) in several human pathogens and diseases. P-gp is a major cause of drug resistance in cancer, parasitic diseases, epilepsy and other disorders. This review article aims to summarize the research findings on the marine natural products with P-glycoprotein inhibitor properties. Natural compounds that modulate P-gp offer great possibilities for semi-synthetic modification to create new drugs and are valuable research tools to understand the function of complex ABC transporters. View Full-Text
Keywords: P-glycoprotein; marine natural products; multidrug resistance P-glycoprotein; marine natural products; multidrug resistance

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Lopez, D.; Martinez-Luis, S. Marine Natural Products with P-Glycoprotein Inhibitor Properties. Mar. Drugs 2014, 12, 525-546.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top